LINC01089 blocks malignant progression of thyroid cancer by binding miR-27b-3p to enhance the FBLN5 protein level

LINC01089 suppresses the malignant progression of breast, colorectal, and non-small cell lung cancers. However, the function of LINC01089 in thyroid cancer has not yet been elucidated. Here, The Cancer Genome Atlas (TCGA) database showed that LINC01089 expression is remarkably reduced in thyroid can...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yong-qin, Huang, Kun-song, Chong, Tsz-Hong, Li, Jin-yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616979/
https://www.ncbi.nlm.nih.gov/pubmed/36306007
http://dx.doi.org/10.1007/s12672-022-00580-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616979/
https://www.ncbi.nlm.nih.gov/pubmed/36306007
http://dx.doi.org/10.1007/s12672-022-00580-4

Ejemplares similares